We can avoid the agonising wait for advances in women’s healthcare

The introduction of the contraceptive pill to the US market marked a revolutionary moment for women’s health. However, initial warnings about serious side effects, including heart attacks and blood clots, were shockingly absent. It took almost ten years before significant actions were taken. In her influential 1969 work, The Doctor’s Case Against The Pill, journalist Barbara Seaman compiled stories from women experiencing serious side effects, leading to US Senate hearings that ultimately mandated vital safety information regarding the drug.

This oversight is not an isolated case. The journey to understanding women’s health issues often seems to stretch endlessly. For example, considerable anecdotal evidence suggested a link between the pill and depression, yet it wasn’t until the 2010s that large-scale studies finally confirmed this association.

Chronic fatigue syndrome (CFS) presents another stark example of how female health issues have been marginalized. With approximately 80% of CFS patients being women, the urgent testimonies regarding its debilitating nature were largely ignored until the emergence of long COVID ignited research interest and funding for similar conditions.

A recent cover story highlights the plight of women suffering from endometriosis, a painful gynecological disorder that has been historically under-researched. Many have reported symptoms suggesting an autoimmune illness for decades, yet only recently have investigations into potential connections gained momentum. This year, a breakthrough analysis revealed a shared genetic pathway that links endometriosis to autoimmune conditions, potentially paving the way for innovative treatments.

The delay in addressing these significant health concerns can largely be attributed to inadequate funding and a societal discomfort surrounding women’s health issues. It’s crucial to recognize that the concerns and experiences of women often receive less attention and are met with skepticism. The voices of thousands of patients crying for recognition must not go unheard. The need for rigorous research is vital for substantiated medical guidance, but that process can be expedited when we prioritize listening to patients, particularly women, and their experiences.